5-Amino-1MQ 10MG is a small-molecule research compound investigated in controlled laboratory studies of NNMT activity, cellular metabolism, biochemical signaling, and metabolic pathway research. For research and analytical applications only.
AOD-9604 10mg is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (hGH), corresponding to amino acids 176–191 with a modified N-terminal tyrosine residue.
AOD-9604 has been investigated in preclinical research involving lipid metabolism, adipocyte biology, and metabolic signaling pathways. It remains an investigational compound without established clinical efficacy for weight management.
LIPO-C 10 mL is a liquid research formulation containing L-Carnitine and Cyanocobalamin (Vitamin B12). Third-party LC-MS identity tested with Certificate of Analysis available. Intended strictly for laboratory research purposes only. Not for human or veterinary use.
MOTS-C 10MG is a mitochondrial-derived research peptide investigated in controlled laboratory studies of mitochondrial signaling, cellular metabolism, energy-regulation pathways, and metabolic biochemistry. For research and analytical applications only.
MOTS-C 40MG is a mitochondrial-derived research peptide investigated in controlled laboratory studies of mitochondrial signaling, cellular metabolism, energy-regulation pathways, and metabolic biochemistry. For research and analytical applications only.
GLP-1S 10MG is a GLP-1 receptor research compound. For research and analytical applications only.
RP-2T 10MG is a dual-receptor research compound investigated in controlled laboratory studies of GLP-1 and GIP receptor signaling, metabolic pathways, receptor interactions, and peptide pharmacology. For research and analytical applications only.
RP-2T 20MG is a dual-receptor research compound investigated in controlled laboratory studies of GLP-1 and GIP receptor signaling, metabolic pathways, receptor interactions, and peptide pharmacology. For research and analytical applications only.
RP-2T 40MG is a dual-receptor research compound investigated in controlled laboratory studies of GLP-1 and GIP receptor signaling, metabolic pathways, receptor interactions, and peptide pharmacology. For research and analytical applications only.
RP-3R 12MG is a multi-receptor research compound investigated in controlled laboratory studies of GLP-1, GIP, and glucagon receptor signaling, metabolic pathways, receptor interactions, and peptide pharmacology. For research and analytical applications only.
GLP-3R 24MG is a multi-receptor research compound investigated in controlled laboratory studies of GLP-1, GIP, and glucagon receptor signaling, metabolic pathways, receptor interactions, and peptide pharmacology. For research and analytical applications only.
GLP-3R 48MG is a multi-receptor research compound investigated in controlled laboratory studies of GLP-1, GIP, and glucagon receptor signaling, metabolic pathways, receptor interactions, and peptide pharmacology. For research and analytical applications only.
RP-3R/Cagrilintide 12.5MG/2.5MG is a dual-compound research blend investigated in controlled laboratory studies of metabolic receptor signaling, peptide interactions, biochemical pathway research, and receptor pharmacology. For research and analytical applications only.
GLP-3R/Tesamorelin 10MG/10MG is a dual-compound research blend investigated in controlled laboratory studies of multi-receptor signaling, GHRH pathways, metabolic signaling, and peptide interactions. For research and analytical applications only.